BIODESIX, INC. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
BIODESIX, INC. (BDSX) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of $3.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2023-03-06
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2022-12-31 was -$141.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2021-12-31 was -$210.00K, a 111.65% decline year-over-year.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2021-09-30 was -$218.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2021-06-30 was -$223.00K.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2022 was $3.50M.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2021 was -$875.00K, a 148.40% decline from fiscal 2020.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2020 was $1.81M.
- BIODESIX, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2019 was -$16.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.50M 10-K · filed 2023-03-06 | ||
| 2022-09-30 | $3.65M 10-Q · filed 2022-11-03 | |||
| 2021-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$428.00K derived: sum of 2 quarters · filed 2023-03-06 | -$651.00K derived: sum of 3 quarters · filed 2023-03-06 | -$875.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$441.00K derived: sum of 2 quarters · filed 2021-11-15 | -$665.00K 10-Q · filed 2021-11-15 | $1.14M derived: sum of 4 quarters · filed 2022-03-14 |
| 2021-06-30 | -$223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$447.00K 10-Q · filed 2021-08-10 | $1.36M derived: sum of 3 quarters · filed 2022-03-14 | |
| 2021-03-31 | -$224.00K 10-Q · filed 2021-05-11 | $1.58M derived: sum of 2 quarters · filed 2022-03-14 | ||
| 2020-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.81M 10-K · filed 2022-03-14 | ||
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-15 | |||
| 2020-03-31 | $82.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | -$16.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |